Viewing Study NCT04294667


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-26 @ 1:30 PM
Study NCT ID: NCT04294667
Status: COMPLETED
Last Update Posted: 2025-05-04
First Post: 2020-02-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Organization: